Yekeduz, E. Et Al. 2022. Clinical outcomes of concomitant use of proton pump inhibitors and regorafenib in patients with metastatic colorectal cancer: A multicenter study. JOURNAL OF CLINICAL ONCOLOGY , vol.40, no.4 .

Yekeduz, E., Ozbay, M. F., Caglayan, D., Yildirim, A., Erol, C., Yildirim, H. C., ... Tunc, S.(2022). Clinical outcomes of concomitant use of proton pump inhibitors and regorafenib in patients with metastatic colorectal cancer: A multicenter study. JOURNAL OF CLINICAL ONCOLOGY , vol.40, no.4.

Yekeduz, EMRE Et Al. "Clinical outcomes of concomitant use of proton pump inhibitors and regorafenib in patients with metastatic colorectal cancer: A multicenter study," JOURNAL OF CLINICAL ONCOLOGY , vol.40, no.4, 2022

Yekeduz, EMRE Et Al. "Clinical outcomes of concomitant use of proton pump inhibitors and regorafenib in patients with metastatic colorectal cancer: A multicenter study." JOURNAL OF CLINICAL ONCOLOGY , vol.40, no.4, 2022

Yekeduz, E. Et Al. (2022) . "Clinical outcomes of concomitant use of proton pump inhibitors and regorafenib in patients with metastatic colorectal cancer: A multicenter study." JOURNAL OF CLINICAL ONCOLOGY , vol.40, no.4.

@article{article, author={EMRE YEKEDÜZ Et Al. }, title={Clinical outcomes of concomitant use of proton pump inhibitors and regorafenib in patients with metastatic colorectal cancer: A multicenter study}, journal={JOURNAL OF CLINICAL ONCOLOGY}, year=2022}